Celltech books long run at Lonza facility
Lonza Biotec is to manufacture PEGylated antibody fragment-based
drugs for Celltech under the terms of a new agreement between the
two companies. The two companies have also reached an agreement on
a prior deal relating to Celltech's...
Crucell revenues slide in 2Q
Dutch biotechnology company Crucell has reported a decline in
revenues for the second quarter of 2003, down 62 per cent to €1.1
Denmark booms on back of US exports
Danish pharmaceutical companies increased their sales to overseas
countries by 20 per cent in the first four months of this year
compared with the same period of 2002, according to Invest In
Merck cuts activities in France
Merck KGaA has trimmed down its operations in France with the
closure of a site at Lacassagne focusing on preclinical R&D and
Joint venture takes Profile towards US presence
A joint venture between UK inhaler specialist Profile and generics
company Breath opens up a new market valued at $1 billion
€2bn credit facility for Degussa
Germany's third largest chemical company has raised € 2 bn of
credit lines by means of a syndicated facility with a group of
leading international banks.
Chiron collars PowderJect
Chiron's has completed its acquisition of UK vaccine and drug
delivery specialist PowderJect, making it the second-largest
manufacturer of flu vaccines worldwide.
Whatman liquidates German unit
Whatman has decided to wind down the operations of its German
subsidiary Biometra, taking a £10.1 million charge in the process.
The move fends off a patent infringement challenge from Applied
Nitto Denko buys Elan's patch business
Nitto Denko is to buy Elan Transdermal Technologies in the first
stage of a strategy to roll-out Nitto's drug delivery technologies
around the world.
Orion closes down Danish manufacturing
Troubled Finnish group Orion has decided to close down its
pharmaceutical manufacturing operations in Denmark in a bid to save
Caliper gets OK for Zymark purchase
Caliper Technologies has been given the go-ahead by the US federal
Trade Commission for its $71 million cash and stock acquisition of
Zymark, a specialist in laboratory automation and robotics
DSM takes stake in chiral compound specialist
DSM has taken a 25 per cent interest in Nijmegen, Netherlands-based
Chiralix in move which both expands DSM's capabilities in
early-stage drug development and Chiralix' position in
Biotrace taps into Scandinavia with Maltec buy
Microbiology specialist Biotrace has continued its expansion into
the healthcare sector with the acquisition of Denmark's Maltec,
helping it to target Scandinavia's strong pharma sector
Pfizer to sell Pharmacia diagnostics unit
Pfizer is considering the sale of its Pharmacia Diagnostics
business, acquired alongside the rest of Pharmacia in a $60 billion
deal that concluded in April.
McCormick sells packaging ops to Kerr
US food company McCormick & Co looks set to sell its packaging
activities to Kerr Group in a transaction valued at $142.5 million.